Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Capital Expenditures of $2321.0 for Q2 2026, down 45.49% year-over-year from $4258.0 in Q2 2025, and down 3.73% on a QoQ basis from $2411.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Capital Expenditures (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Capital Expenditures history runs 17 years deep, the most recent figure standing at $2321.0 for Q2 2026.
- Capital Expenditures for Q2 2026 came in at $2321.0, down 45.49% year-over-year; the trailing twelve-month figure through Apr 2026 was $7118.0 (down 95.64% YoY), and the FY2025 annual result was $6644.0, down 95.84% from the prior year.
- Capital Expenditures came in at $2321.0 for Q2 2026 at Pharma-Bio Serv, down from $2411.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $157015.0 in Q4 2024 to a low of -$1580.0 in Q4 2023.
- A 5-year average of $13175.9 and a median of $2087.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures tumbled 113.02% in 2023 and soared 10037.66% in 2024, its largest moves.
- Over 5 years, Capital Expenditures stood at $12137.0 in 2022, then slumped by 113.02% to -$1580.0 in 2023, then soared by 10037.66% to $157015.0 in 2024, then slumped by 99.78% to $350.0 in 2025, then jumped by 563.14% to $2321.0 in 2026.
- The last three Capital Expenditures figures came in at $2321.0 (Q2 2026), $2411.0 (Q1 2026), and $350.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.75 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.67 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 15.93 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 28,000.00 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 118,000.00 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 2.25 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 15.33 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 12.44 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 2,321.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2,321.00 |
| Apr 30, 2026 | 2,321.00 |
| Jan 31, 2026 | 2,411.00 |
| Jan 31, 2026 | 2,411.00 |
| Oct 31, 2025 | 350.00 |
| Oct 31, 2025 | 350.00 |
| Jul 31, 2025 | 2,036.00 |
| Jul 31, 2025 | 2,036.00 |
| Apr 30, 2025 | 4,258.00 |
| Apr 30, 2025 | 4,258.00 |
| Oct 31, 2024 | 157,015.00 |
| Oct 31, 2024 | 157,015.00 |
| Jul 31, 2024 | 1,908.00 |
| Jul 31, 2024 | 1,908.00 |
| Jan 31, 2024 | 820.00 |
| Jan 31, 2024 | 820.00 |
| Oct 31, 2023 | -1,580.00 |
| Oct 31, 2023 | -1,580.00 |
| Apr 30, 2023 | 764.00 |
| Apr 30, 2023 | 764.00 |